ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

INVA Innoviva Inc

15.26
0.27 (1.80%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Innoviva Inc INVA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.27 1.80% 15.26 06:16:11
개장가 저가 고가 종가 전일 종가
15.01 14.98 15.285 15.26 14.99
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202420:00BWInnoviva Specialty Therapeutics’ Positive Phase 3 Oral..
08/03/202409:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202409:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202408:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/03/202406:15EDGAR2Form 8-K - Current report
01/03/202406:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
23/02/202411:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202411:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202421:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/01/202411:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202410:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/11/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202322:30EDGAR2Form 8-K - Current report
02/11/202305:30EDGAR2Form 8-K - Current report
02/11/202305:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
02/11/202305:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
19/09/202321:30BWInnoviva to Participate in the Cantor Global Healthcare..
18/09/202321:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
01/09/202309:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/09/202302:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202306:24EDGAR2Form 8-K - Current report
26/08/202305:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
08/08/202305:42EDGAR2Form 8-K - Current report
03/08/202310:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/08/202305:15EDGAR2Form 8-K - Current report
03/08/202305:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
11/07/202321:16EDGAR2Form 8-K - Current report
07/06/202305:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
24/05/202308:10DJNFDA Approves Innoviva's Bacterial Pneumonia Treatment
24/05/202307:42BWInnoviva Specialty Therapeutics Announces FDA Approval for..
12/05/202307:45BWResults from Pivotal Phase 3 ATTACK Trial of Investigational..
10/05/202305:32BWInnoviva Reports First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock